{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:54:04Z","timestamp":1793656444963,"version":"4.5.1"},"reference-count":149,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Immune cell migration plays a pivotal role in coordinating inflammatory responses and maintaining immune surveillance. Here, we provide a comprehensive overview of the migratory behaviors of key immune cell subsets, including Th1, Th2, regulatory T cells, macrophages, dendritic cells, and neutrophils and the molecular mechanisms that guide their trafficking from lymphoid organs to inflamed tissues. We highlight the stepwise migration cascade: priming in secondary lymphoid organs, trafficking through blood vessels, adhesion to endothelium, and extravasation into tissues. Each step is critically regulated by chemokines, selectins, integrins, and proteases. We also examine current pharmacological strategies that target immune cell migration in inflammatory diseases, such as integrin blockers and chemokine receptor antagonists, emphasizing both therapeutic potential and clinical limitations. In addition, we discuss emerging technologies including intravital imaging, CRISPR-based screening, and computational modeling that provide novel insights into immune cell dynamics and may guide the development of next generation migration-targeted therapies. Overall, this review integrates fundamental immunological principles with translational medicine by identifying key challenges, unresolved controversies, and future directions in the therapeutic modulation of immune cell migration.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1650760","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:17:40Z","timestamp":1758773860000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Targeting immune cell migration as therapy for inflammatory disease: a review"],"prefix":"10.3389","volume":"16","author":[{"given":"Bingfeng","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingli","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90337-9","article-title":"Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm","volume":"76","author":"Springer","year":"1994","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nri2156","article-title":"Getting to the site of inflammation: the leukocyte adhesion cascade updated","volume":"7","author":"Ley","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.03.011","article-title":"Role of the microbiota in immunity and inflammation","volume":"157","author":"Belkaid","year":"2014","journal-title":"Cell"},{"key":"B5","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41392-025-02168-0","article-title":"Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics","volume":"10","author":"Dai","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70246","article-title":"New mechanisms and therapeutic targets in systemic lupus erythematosus","volume":"6","author":"Tian","year":"2025","journal-title":"MedComm (2020)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1599473","article-title":"Rituximab as the first-line treatment in newly diagnosed systemic lupus erythematosus","volume":"16","author":"Wang","year":"2025","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2025.06.019","article-title":"Disease modification in psoriasis through early interleukin 17 inhibitor intervention: A retrospective cohort study","author":"Chen","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1038\/s41467-025-57211-z","article-title":"Cooperation of TRADD- and RIPK1-dependent cell death pathways in maintaining intestinal homeostasis","volume":"16","author":"Sun","year":"2025","journal-title":"Nat Commun"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-161141","article-title":"The gut microbiota and Alzheimer's disease","volume":"58","author":"Jiang","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s12640-025-00740-8","article-title":"Associations among angiotensin-converting enzyme, neuroinflammation, and cerebrospinal fluid biomarkers of Alzheimer's disease in non-dementia adults","volume":"43","author":"Wang","year":"2025","journal-title":"Neurotox Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.3390\/ijms22041845","article-title":"Aquaporins in immune cells and inflammation: new targets for drug development","volume":"22","author":"da Silva","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.750480","article-title":"Pannexin channel regulation of cell migration: focus on immune cells","volume":"12","author":"Harcha","year":"2021","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-015-1835-0","article-title":"Molecular mechanisms of CD8(+) T cell trafficking and localization","volume":"72","author":"Nolz","year":"2015","journal-title":"Cell Mol Life Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s10020-024-01059-4","article-title":"Conventional type 1 dendritic cells in the lymph nodes aggravate neuroinflammation after spinal cord injury by promoting CD8(+) T cell expansion","volume":"31","author":"Wang","year":"2025","journal-title":"Mol Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.3737","article-title":"Mouse dendritic cells in the steady state: Hypoxia, autophagy, and stem cell factor","volume":"40","author":"Barroeta Seijas","year":"2022","journal-title":"Cell Biochem Funct"},{"key":"B18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0092-8674(00)80059-8","article-title":"CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs","volume":"99","author":"F\u00f6rster","year":"1999","journal-title":"Cell"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1084\/jem.173.3.721","article-title":"Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation","volume":"173","author":"Linsley","year":"1991","journal-title":"J Exp Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01289-w","article-title":"Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation","volume":"23","author":"Kennedy","year":"2022","journal-title":"Nat Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1496992","article-title":"Research progress of CD80 in the development of immunotherapy drugs","volume":"15","author":"Li","year":"2024","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41392-021-00823-w","article-title":"T cell receptor (TCR) signaling in health and disease","volume":"6","author":"Shah","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.cell.2024.11.031","article-title":"Inflammation switches the chemoattractant requirements for naive lymphocyte entry into lymph nodes","volume":"188","author":"Chen","year":"2025","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.immuni.2014.10.008","article-title":"Leukocyte migration into inflamed tissues","volume":"41","author":"Nourshargh","year":"2014","journal-title":"Immunity"},{"key":"B25","doi-asserted-by":"publisher","first-page":"110528","DOI":"10.1016\/j.isci.2024.110528","article-title":"T cell trafficking in human chronic inflammatory diseases","volume":"27","author":"Giovenzana","year":"2024","journal-title":"iScience"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1071553","article-title":"Alpha4 beta7 integrin controls Th17 cell trafficking in the spinal cord leptomeninges during experimental autoimmune encephalomyelitis","volume":"14","author":"Rossi","year":"2023","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.624184","article-title":"Dysregulation of leukocyte trafficking in type 2 diabetes: mechanisms and potential therapeutic avenues","volume":"9","author":"Pezhman","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1502440","article-title":"Pannexin1 channels are required for chemokine-mediated migration of CD4+ T lymphocytes: role in inflammation and experimental autoimmune encephalomyelitis","volume":"196","author":"Velasquez","year":"2016","journal-title":"J Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.7150\/thno.87130","article-title":"Midline-1 regulates effector T cell motility in experimental autoimmune encephalomyelitis via mTOR\/microtubule pathway","volume":"14","author":"Wei","year":"2024","journal-title":"Theranostics"},{"key":"B30","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.immuni.2019.06.026","article-title":"Programming of distinct chemokine-dependent and -independent search strategies for th1 and th2 cells optimizes function at inflamed sites","volume":"51","author":"Gaylo-Moynihan","year":"2019","journal-title":"Immunity"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1149203","article-title":"T-helper cells and their cytokines in pathogenesis and treatment of asthma","volume":"14","author":"Ji","year":"2023","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.864628","article-title":"Moving to the outskirts: interplay between regulatory T cells and peripheral tissues","volume":"13","author":"Estrada Brull","year":"2022","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1278759","article-title":"Treg in inborn errors of immunity: gaps, knowns and future perspectives","volume":"14","author":"Kennedy-Batalla","year":"2023","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/jleuko\/qiaf073","article-title":"Macrophage polarization, inflammatory monocytes, and impaired MDSCs are associated with murine and human immune aplastic anemia","volume":"117","author":"Glass","year":"2025","journal-title":"J Leukoc Biol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202303298","article-title":"Reshaping intratumoral mononuclear phagocytes with antibody-opsonized immunometabolic nanoparticles","volume":"10","author":"Liu","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02511-4","article-title":"Multi-omic analysis of chronic myelomonocytic leukemia monocytes reveals metabolic and immune dysregulation leading to altered macrophage polarization","volume":"39","author":"Addinsell","year":"2025","journal-title":"Leukemia"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-021-03978-5","article-title":"Metabolic regulation of RA macrophages is distinct from RA fibroblasts and blockade of glycolysis alleviates inflammatory phenotype in both cell types","volume":"78","author":"Umar","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"B38","doi-asserted-by":"publisher","first-page":"100825","DOI":"10.1016\/j.jlr.2025.100825","article-title":"Glucosylated cholesterol accumulates in atherosclerotic lesions and impacts macrophage immune response","volume":"66","author":"Marques","year":"2025","journal-title":"J Lipid Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/ni1309","article-title":"Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2","volume":"7","author":"Serbina","year":"2006","journal-title":"Nat Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1038\/s41467-025-58289-1","article-title":"Immunotherapy with conventional type-1 dendritic cells induces immune memory and limits tumor relapse","volume":"16","author":"Heras-Murillo","year":"2025","journal-title":"Nat Commun"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1321051","DOI":"10.3389\/fimmu.2023.1321051","article-title":"Dendritic cells: the yin and yang in disease progression","volume":"14","author":"Jim\u00e9nez-Cortegana","year":"2023","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1554492","article-title":"Sequential activation of conventional and plasmacytoid dendritic cells in autoimmune pancreatitis and systemic lupus erythematosus: similarities and dissimilarities","volume":"16","author":"Hara","year":"2025","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/all.16337","article-title":"How type-2 dendritic cells induce Th2 differentiation: Instruction, repression, or fostering T cell-T cell communication","volume":"80","author":"Ronchese","year":"2025","journal-title":"Allergy"},{"key":"B44","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.1038\/s41467-021-25307-x","article-title":"CD11b(+) lung dendritic cells at different stages of maturation induce Th17 or Th2 differentiation","volume":"12","author":"Izumi","year":"2021","journal-title":"Nat Commun"},{"key":"B45","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s41232-025-00388-z","article-title":"Dendritic cell heterogeneity and its role in connective tissue diseases","volume":"45","author":"Yamada","year":"2025","journal-title":"Inflammation Regen"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1602174","article-title":"Fungal immunization potentiates CD4(+) T cell-independent cDC2 responses for cross-presentation","volume":"16","author":"Kulkarni","year":"2025","journal-title":"Front Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/exd.70128","article-title":"Psychological stress overactivates IL-23\/th17 inflammatory axis and increases cDC2 in imiquimod-induced psoriasis models of C57BL\/6 mice","volume":"34","author":"Tang","year":"2025","journal-title":"Exp Dermatol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2025.2536888","article-title":"Progress in the use of type I interferon blockade in systemic lupus erythematosus","author":"Miceli","year":"2025","journal-title":"Expert Opin Biol Ther"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1016\/j.cell.2025.03.020","article-title":"Ror\u03b3t-positive dendritic cells are required for the induction of peripheral regulatory T cells in response to oral antigens","volume":"188","author":"Rodrigues","year":"2025","journal-title":"Cell"},{"key":"B50","doi-asserted-by":"publisher","first-page":"789814","DOI":"10.1155\/2013\/789814","article-title":"Therapeutic potential of tolerogenic dendritic cells in IBD: from animal models to clinical application","volume":"2013","author":"Cabez\u00f3n","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"103861","DOI":"10.1016\/j.autrev.2025.103861","article-title":"Mesenchymal stem cell in immunomodulation of dendritic cells: Implications for inflammatory bowel disease therapy","volume":"24","author":"Song","year":"2025","journal-title":"Autoimmun Rev"},{"key":"B52","article-title":"The expanding role of anti-IL-12 and\/or anti-IL-23 antibodies in the treatment of inflammatory bowel disease","volume":"15","author":"Kashani","year":"2019","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.22244","article-title":"Nanovaccines: Immunogenic tumor antigens, targeted delivery, and combination therapy to enhance cancer immunotherapy","volume":"85","author":"Jahanafrooz","year":"2024","journal-title":"Drug Dev Res"},{"key":"B54","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s11882-018-0786-6","article-title":"Mast cell interactions and crosstalk in regulating allergic inflammation","volume":"18","author":"Velez","year":"2018","journal-title":"Curr Allergy Asthma Rep"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S480644","article-title":"Quercetin attenuates MRGPRX2-mediated mast cell degranulation via the myD88\/IKK\/NF-\u03baB and PI3K\/AKT\/ Rac1\/Cdc42 pathway","volume":"17","author":"Zhao","year":"2024","journal-title":"J Inflammation Res"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.3390\/nu17091476","article-title":"Quercetin and its lecithin-based formulation: potential applications for allergic diseases based on a narrative review","volume":"17","author":"Naso","year":"2025","journal-title":"Nutrients"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.70018","article-title":"Cromolyn sodium and masitinib combination inhibits fibroblast-myofibroblast transition and exerts additive cell-protective and antioxidant effects on a bleomycin-induced in vitro fibrosis model","volume":"12","author":"G\u00f6ksu","year":"2024","journal-title":"Pharmacol Res Perspect"},{"key":"B58","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.3390\/ijms23042249","article-title":"The multifaceted roles of mast cells in immune homeostasis, infections and cancers","volume":"23","author":"Sobiepanek","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.3A0820-207R","article-title":"Neutrophil recruitment by chemokines Cxcl1\/KC and Cxcl2\/MIP2: Role of Cxcr2 activation and glycosaminoglycan interactions","volume":"109","author":"Sawant","year":"2021","journal-title":"J Leukoc Biol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-09-3578","article-title":"Constitutive homing of mast cell progenitors to the intestine depends on autologous expression of the chemokine receptor CXCR2","volume":"105","author":"Abonia","year":"2005","journal-title":"Blood"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/febs.16266","article-title":"Specialized pro-resolving mediators: biosynthesis and biological role in bacterial infections","volume":"289","author":"Jordan","year":"2022","journal-title":"FEBS J"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-023-01410-2","article-title":"CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial","volume":"42","author":"Armstrong","year":"2024","journal-title":"Invest New Drugs"},{"key":"B63","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12931-020-01401-4","article-title":"CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial","volume":"21","author":"Lazaar","year":"2020","journal-title":"Respir Res"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1111\/eci.14015","article-title":"Reparixin improves survival in critically ill and transplant patients: A meta-analysis","volume":"53","author":"Piersanti","year":"2023","journal-title":"Eur J Clin Invest"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adi0672","article-title":"A dynamic atlas of immunocyte migration from the gut","volume":"9","author":"Galv\u00e1n-Pe\u00f1a","year":"2024","journal-title":"Sci Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41421-024-00749-x","article-title":"Packaged release and targeted delivery of cytokines by migrasomes in circulation","volume":"10","author":"Jiao","year":"2024","journal-title":"Cell Discov"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1111\/febs.14466","article-title":"A guide to chemokines and their receptors","volume":"285","author":"Hughes","year":"2018","journal-title":"FEBS J"},{"key":"B68","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s42003-025-07778-6","article-title":"Development of chemokine network inhibitors using combinatorial saturation mutagenesis","volume":"8","author":"Kryukova","year":"2025","journal-title":"Commun Biol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c01588","article-title":"Discovery of the potent, selective, orally available CXCR7 antagonist ACT-1004-1239","volume":"63","author":"Richard-Bildstein","year":"2020","journal-title":"J Med Chem"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2025.03.046","article-title":"Encoding and decoding selectivity and promiscuity in the human chemokine-GPCR interaction network","author":"Kleist","year":"2025","journal-title":"Cell"},{"key":"B71","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s10020-025-01161-1","article-title":"Curcumin inhibits ferroptosis-mediated vascular occlusion by regulating the CXCL10\/CXCR3 axis in retinopathy of prematurity","volume":"31","author":"Niu","year":"2025","journal-title":"Mol Med"},{"key":"B72","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s41232-025-00375-4","article-title":"The dual roles of chemokines in peripheral nerve injury and repair","volume":"45","author":"Wang","year":"2025","journal-title":"Inflammation Regen"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1101\/2025.04.24.650529","article-title":"Activating the CXCR3\/CXCL10 pathway overrides tumor immune suppression by enhancing immune trafficking and effector cell priming in head and neck squamous cell carcinoma","author":"Shinn","year":"2025","journal-title":"bioRxiv"},{"key":"B74","doi-asserted-by":"publisher","first-page":"jcs262066","DOI":"10.1242\/jcs.262066","article-title":"Extravasation of immune and tumor cells from an endothelial perspective","volume":"137","author":"Dupas","year":"2024","journal-title":"J Cell Sci"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1480152","article-title":"Csk controls leukocyte extravasation via local regulation of Src family kinases and cortactin signaling","volume":"15","author":"Stegmeyer","year":"2024","journal-title":"Front Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1558228","article-title":"Beyond CCR7: dendritic cell migration in type 2 inflammation","volume":"16","author":"Meloun","year":"2025","journal-title":"Front Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adc9584","article-title":"CCR7 acts as both a sensor and a sink for CCL19 to coordinate collective leukocyte migration","volume":"8","author":"Alanko","year":"2023","journal-title":"Sci Immunol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3390\/pharmaceutics17010065","article-title":"HIFU-CCL19\/21 axis enhances dendritic cell vaccine efficacy in the tumor microenvironment","volume":"17","author":"Baek","year":"2025","journal-title":"Pharmaceutics"},{"key":"B79","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s00262-025-04120-1","article-title":"Preclinical evaluation of a CCL19 immune-potentiated DNA cancer vaccine","volume":"74","author":"Kofoed","year":"2025","journal-title":"Cancer Immunol Immunother"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1093\/jimmun\/vkaf136","article-title":"Stromal cell-derived chemokines modulate immune cells in inflammation: New findings and future perspectives","author":"Zhang","year":"2025","journal-title":"J Immunol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.3390\/biomedicines11071995","article-title":"Cell adhesion molecules in fibrotic diseases","volume":"11","author":"Hu","year":"2023","journal-title":"Biomedicines"},{"key":"B82","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.3390\/molecules25122835","article-title":"Selectins-the two Dr. Jekyll and Mr. Hyde faces of adhesion molecules-A review","volume":"25","author":"Tvaro\u0161ka","year":"2020","journal-title":"Molecules"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2015.10","article-title":"Integrin-based therapeutics: biological basis, clinical use and new drugs","volume":"15","author":"Ley","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"B84","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1056\/NEJMoa044397","article-title":"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis","volume":"354","author":"Polman","year":"2006","journal-title":"N Engl J Med"},{"key":"B85","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJMoa1215734","article-title":"Vedolizumab as induction and maintenance therapy for ulcerative colitis","volume":"369","author":"Feagan","year":"2013","journal-title":"N Engl J Med"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215739","article-title":"Vedolizumab as induction and maintenance therapy for Crohn's disease","volume":"369","author":"Sandborn","year":"2013","journal-title":"N Engl J Med"},{"key":"B87","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/02656736.2019.1647357","article-title":"Regulation of immune cell trafficking by febrile temperatures","volume":"36","author":"Lin","year":"2019","journal-title":"Int J Hyperthermia"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2025.02.004","article-title":"Protease regulation of tumor-immune cell symbiosis","volume":"11","author":"Pang","year":"2025","journal-title":"Trends Cancer"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2017.11.007","article-title":"The gelatinases, MMP-2 and MMP-9, as fine tuners of neuroinflammatory processes","author":"Hannocks","year":"2019","journal-title":"Matrix Biol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202451664","article-title":"Interleukin-8\/matrix metalloproteinase-9 axis impairs wound healing in type 2 diabetes through neutrophil extracellular traps-fibroblast crosstalk","volume":"55","author":"Tsilingiris","year":"2025","journal-title":"Eur J Immunol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3892\/ijo.2025.5734","article-title":"Tumor\u2212associated neutrophils: Critical regulators in cancer progression and therapeutic resistance (Review)","volume":"66","author":"Hou","year":"2025","journal-title":"Int J Oncol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"9739","DOI":"10.3390\/ijms21249739","article-title":"The roles of matrix metalloproteinases and their inhibitors in human diseases","volume":"21","author":"Cabral-Pacheco","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abn3774","article-title":"Therapeutic strategies targeting uPAR potentiate anti-PD-1 efficacy in diffuse-type gastric cancer","volume":"8","author":"Qin","year":"2022","journal-title":"Sci Adv"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.06.050","article-title":"Exosomal miRNA-26b-5p from PRP suppresses NETs by targeting MMP-8 to promote diabetic wound healing","volume":"372","author":"Rui","year":"2024","journal-title":"J Control Release"},{"key":"B95","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1124\/jpet.122.001384","article-title":"Endothelial-specific targeting of rhoA signaling via CD31 antibody-conjugated nanoparticles","volume":"385","author":"Lahooti","year":"2023","journal-title":"J Pharmacol Exp Ther"},{"key":"B96","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceb.2009.05.003","article-title":"Mechanical modes of 'amoeboid' cell migration","volume":"21","author":"L\u00e4mmermann","year":"2009","journal-title":"Curr Opin Cell Biol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.08.054","article-title":"Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern Cooperative Oncology Group trial E2196","volume":"22","author":"Sparano","year":"2004","journal-title":"J Clin Oncol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.170","article-title":"Phase III study of matrix metalloproteinase inhibitor prinomastat in non-small-cell lung cancer","volume":"23","author":"Bissett","year":"2005","journal-title":"J Clin Oncol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.897626","article-title":"Editorial: immune cell migration in health and disease","volume":"13","author":"Renkawitz","year":"2022","journal-title":"Front Immunol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1038\/s44222-022-00016-2","article-title":"Targeted modulation of immune cells and tissues using engineered biomaterials","volume":"1","author":"Yousefpour","year":"2023","journal-title":"Nat Rev Bioeng"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1556196","article-title":"CXCR3 inhibitors for therapeutic interventions: current status and perspectives","volume":"16","author":"Huo","year":"2025","journal-title":"Front Pharmacol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.3390\/biomedicines11102621","article-title":"Small molecule targeting immune cells: A novel approach for cancer treatment","volume":"11","author":"Singh","year":"2023","journal-title":"Biomedicines"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-022-00927-z","article-title":"The two sides of siponimod: evidence for brain and immune mechanisms in multiple sclerosis","volume":"36","author":"Cohan","year":"2022","journal-title":"CNS Drugs"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-022-11166-z","article-title":"Siponimod vs placebo in active secondary progressive multiple sclerosis: a post hoc analysis from the phase 3 EXPAND study","volume":"269","author":"Gold","year":"2022","journal-title":"J Neurol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30475-6","article-title":"Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study","volume":"391","author":"Kappos","year":"2018","journal-title":"Lancet"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-023-00539-9","article-title":"Natalizumab treatment of relapsing remitting multiple sclerosis has no long-term effects on the proportion of circulating regulatory T cells","volume":"12","author":"Tanasescu","year":"2023","journal-title":"Neurol Ther"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1416074","article-title":"Frequent detection of IFN-gamma -producing memory effector and effector T cells in patients with progressive multifocal leukoencephalopathy","volume":"15","author":"de Go\u00ebr de Herve","year":"2024","journal-title":"Front Immunol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults","volume":"68","author":"Lamb","year":"2019","journal-title":"Gut"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-222501","article-title":"Low-dose interleukin-2 therapy in active systemic lupus erythematosus (LUPIL-2): a multicentre, double-blind, randomised and placebo-controlled phase II trial","volume":"81","author":"Humrich","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"B110","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1016\/j.immuni.2024.07.016","article-title":"Interleukin-2 immunotherapy reveals human regulatory T cell subsets with distinct functional and tissue-homing characteristics","volume":"57","author":"Raeber","year":"2024","journal-title":"Immunity"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2019.05.001","article-title":"Low-dose interleukin-2 ameliorates colitis in a preclinical humanized mouse model","volume":"8","author":"Goettel","year":"2019","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201202513","article-title":"Bioinspired controlled release of CCL22 recruits regulatory T cells in vivo","volume":"24","author":"Jhunjhunwala","year":"2012","journal-title":"Adv Mater"},{"key":"B113","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1084\/jem.192.6.899","article-title":"CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis","volume":"192","author":"Fife","year":"2000","journal-title":"J Exp Med"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70789","article-title":"Chemokines: orchestration of the tumor microenvironment and control of hepatocellular carcinoma progression","volume":"14","author":"Yang","year":"2025","journal-title":"Cancer Med"},{"key":"B115","doi-asserted-by":"publisher","first-page":"DMM052084","DOI":"10.1242\/dmm.052084","article-title":"Improving bench-to-bedside translation for acute graft-versus-host disease models","volume":"18","author":"McDaniel Mims","year":"2025","journal-title":"Dis Model Mech"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.956691","article-title":"Role of periostin in inflammatory bowel disease development and synergistic effects mediated by the CCL5-CCR5 axis","volume":"13","author":"Mukanova","year":"2022","journal-title":"Front Immunol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izac151","article-title":"Transcriptional behavior of regulatory T cells predicts IBD patient responses to vedolizumab therapy","volume":"28","author":"Abreu","year":"2022","journal-title":"Inflammation Bowel Dis"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw147","article-title":"Postoperative outcomes in vedolizumab-treated patients undergoing abdominal operations for inflammatory bowel disease","volume":"11","author":"Lightner","year":"2017","journal-title":"J Crohns Colitis"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izad123","article-title":"Mucosal \u03b14\u03b27+ Lymphocytes and MAdCAM+ Venules predict response to vedolizumab in ulcerative colitis","volume":"30","author":"Roosenboom","year":"2024","journal-title":"Inflammation Bowel Dis"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2025.1515340","article-title":"Organoids-on-a-chip: microfluidic technology enables culture of organoids with enhanced tissue function and potential for disease modeling","volume":"13","author":"Papamichail","year":"2025","journal-title":"Front Bioeng Biotechnol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.3390\/cancers17132163","article-title":"Exploring experimental models of colorectal cancer: A critical appraisal from 2D cell systems to organoids, humanized mouse avatars, organ-on-chip, CRISPR engineering, and AI-driven platforms-challenges and opportunities for translational precision oncology","volume":"17","author":"Al-Kabani","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s44222-023-00063-3","article-title":"Human disease models in drug development","author":"Loewa","year":"2023","journal-title":"Nat Rev Bioeng"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1038\/nri3823","article-title":"The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases","volume":"15","author":"Klatzmann","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"4891","DOI":"10.1038\/s41467-025-60082-z","article-title":"Expression of an interleukin-2 partial agonist enhances regulatory T cell persistence and efficacy in mouse autoimmune models","volume":"16","author":"Robert","year":"2025","journal-title":"Nat Commun"},{"key":"B125","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13195-025-01791-x","article-title":"Low-dose interleukin-2 in patients with mild to moderate Alzheimer's disease: a randomized clinical trial","volume":"17","author":"Faridar","year":"2025","journal-title":"Alzheimers Res Ther"},{"key":"B126","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3390\/bios14050225","article-title":"A comprehensive review of organ-on-a-chip technology and its applications","volume":"14","author":"Farhang Doost","year":"2024","journal-title":"Biosensors (Basel)"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.3390\/pharmaceutics13091373","article-title":"3D printing of pharmaceutical application: drug screening and drug delivery","volume":"13","author":"Gao","year":"2021","journal-title":"Pharmaceutics"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3390\/mi16020201","article-title":"Organ-on-a-chip applications in microfluidic platforms","volume":"16","author":"An","year":"2025","journal-title":"Micromachines (Basel)"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1126\/science.1188302","article-title":"Reconstituting organ-level lung functions on a chip","volume":"328","author":"Huh","year":"2010","journal-title":"Science"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2989","article-title":"Microfluidic organs-on-chips","volume":"32","author":"Bhatia","year":"2014","journal-title":"Nat Biotechnol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"115485","DOI":"10.1016\/j.addr.2024.115485","article-title":"Advancing tumor microenvironment and lymphoid tissue research through 3D bioprinting and biofabrication","volume":"217","author":"Mazzaglia","year":"2025","journal-title":"Adv Drug Delivery Rev"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.4c08731","article-title":"High-throughput 3D-printed model of the feto-maternal interface for the discovery and development of preterm birth therapies","volume":"16","author":"Cherukuri","year":"2024","journal-title":"ACS Appl Mater Interfaces"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202201401","article-title":"Organ-on-A-chip models of the blood-brain barrier: recent advances and future prospects","volume":"18","author":"Kawakita","year":"2022","journal-title":"Small"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2018.10.003","article-title":"Towards the development of human immune-system-on-a-chip platforms","volume":"24","author":"Polini","year":"2019","journal-title":"Drug Discov Today"},{"key":"B135","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.ccell.2021.04.014","article-title":"Conserved pan-cancer microenvironment subtypes predict response to immunotherapy","volume":"39","author":"Bagaev","year":"2021","journal-title":"Cancer Cell"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"B137","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s43856-022-00197-2","article-title":"Multiplexed imaging mass cytometry reveals distinct tumor-immune microenvironments linked to immunotherapy responses in melanoma","volume":"2","author":"Xiao","year":"2022","journal-title":"Commun Med (Lond)"},{"key":"B138","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41698-024-00765-w","article-title":"Predicting the tumor microenvironment composition and immunotherapy response in non-small cell lung cancer from digital histopathology images","volume":"8","author":"Patkar","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.cell.2020.07.005","article-title":"Coordinated cellular neighborhoods orchestrate antitumoral immunity at the colorectal cancer invasive front","volume":"182","author":"Sch\u00fcrch","year":"2020","journal-title":"Cell"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1876-x","article-title":"The single-cell pathology landscape of breast cancer","volume":"578","author":"Jackson","year":"2020","journal-title":"Nature"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.516","article-title":"Intravital microscopy to visualize murine small intestinal intraepithelial lymphocyte migration","volume":"2","author":"Fischer","year":"2022","journal-title":"Curr Protoc"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-023-01432-2","article-title":"A genome-wide in vivo CRISPR screen identifies essential regulators of T cell migration to the CNS in a multiple sclerosis model","volume":"26","author":"Kendirli","year":"2023","journal-title":"Nat Neurosci"},{"key":"B143","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41540-024-00419-4","article-title":"Spatial computational modelling illuminates the role of the tumour microenvironment for treating glioblastoma with immunotherapies","volume":"10","author":"Mongeon","year":"2024","journal-title":"NPJ Syst Biol Appl"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.3390\/pr7010037","article-title":"Multiscale agent-based and hybrid modeling of the tumor immune microenvironment","volume":"7","author":"Norton","year":"2019","journal-title":"Processes (Basel)"},{"key":"B145","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12906-021-03488-8","article-title":"Interactions of selected cardiovascular active natural compounds with CXCR4 and CXCR7 receptors: a molecular docking, molecular dynamics, and pharmacokinetic\/toxicity prediction study","volume":"22","author":"Murad","year":"2022","journal-title":"BMC Complement Med Ther"},{"key":"B146","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13321-024-00816-1","article-title":"Prediction of compound-target interaction using several artificial intelligence algorithms and comparison with a consensus-based strategy","volume":"16","author":"Jimenes-Vargas","year":"2024","journal-title":"J Cheminform"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.201400279","article-title":"Stimuli-responsive materials for controlled release of theranostic agents","volume":"24","author":"Wang","year":"2014","journal-title":"Adv Funct Mater"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4333","article-title":"Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery","volume":"13","author":"Torchilin","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"B149","doi-asserted-by":"publisher","first-page":"112318","DOI":"10.1016\/j.isci.2025.112318","article-title":"Inflammation-responsive biomimetic nanoparticles with epigallocatechin-3-gallate for acute lung injury therapy via autophagy enhancement","volume":"28","author":"Han","year":"2025","journal-title":"iScience"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1650760\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:17:42Z","timestamp":1758773862000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1650760\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":149,"alternative-id":["10.3389\/fimmu.2025.1650760"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1650760","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"article-number":"1650760"}}